Hua Yi
Director/Board Member presso Xiamen LP Pharmaceutical Co., Ltd.
Profilo
Hua Yi is currently a Director at CF PharmTech, Inc. and Xiamen LP Pharmaceutical Co., Ltd.
He previously held Director positions at HMT (Xiamen) New Technical Materials Co., Ltd.
and was a Non-Executive Director at TransThera Sciences (Nanjing), Inc. Dr. Yi earned doctorate degrees from East China Normal University and École normale supérieure Paris-Saclay.
Posizioni attive di Hua Yi
| Società | Posizione | Inizio |
|---|---|---|
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Director/Board Member | 31/08/2020 |
CF PharmTech, Inc
 CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Director/Board Member | 01/12/2021 |
Precedenti posizioni note di Hua Yi
| Società | Posizione | Fine |
|---|---|---|
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Director/Board Member | - |
| HMT (XIAMEN) NEW TECHNICAL MATERIALS CO., LTD | Director/Board Member | - |
Formazione di Hua Yi
| École normale supérieure Paris-Saclay | Doctorate Degree |
| East China Normal University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HMT (XIAMEN) NEW TECHNICAL MATERIALS CO., LTD | Process Industries |
| Aziende private | 3 |
|---|---|
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Health Technology |
CF PharmTech, Inc
CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |
- Borsa valori
- Insiders
- Hua Yi
